Smoldering MS: the real MS becomes a tractable problem
Tolebrutinib, a second-generation BTK inhibitor, is the first to show a reduction in disability accumulation in non-relapsing secondary progressive MS…
2024 Revisions to McDonald Diagnostic Criteria for Multiple Sclerosis: Peter Calabresi, MD
For those not sure the reason for this criteria, is it to help doctors Diagnose MS Author(s): Peter A. Calabresi,…
Stuart Schlossman
Help Make an IMPACT on Future MS Treatments
Dear Potential Participant, My name is Tanisha Prater. I am completing a doctoral degree in health sciences at A.T. Still…
Stuart Schlossman
The Effect of Seasonal Changes on Multiple Sclerosis
Do you experience more MS symptoms in some seasons than others? Many of us do, says the blogger Trevis Gleason,…
Stuart Schlossman
A Case Study in Neurotherapeutic Clinical Trial Design and Conduct
September 2024 New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities Early this summer, Cleveland Clinic researchers enrolled the…
Stuart Schlossman
Let’s Move From Categorizing MS by Clinical Phenotype to Underlying Disease Mechanisms
September 19, 2024 – Meaningful characterization is critical to advancing research and care, review authors contend The currently used phenotypic…
Stuart Schlossman
Could Serum Neurofilament Light (sNFL) Chain Level Help Guide MS Management?
April 2024 Perhaps, with caveats: sNfL elevation has low sensitivity and lags MRI activity by at least a month Serum…
Stuart Schlossman
Factors Influencing Time Delays in Initiating High-Efficacy Treatment in Multiple Sclerosis: Valentin Krüger, MD
September 19, 2024 By Valentin Krüger, MD / Isabella Ciccone, MPH — Fact checked by Marco Meglio The neurology resident at the…
Stuart Schlossman
Cell-based therapeutic strategies for multiple sclerosis
Brain. 2017 Nov; 140(11): 2776–2796. Published online 2017 Jul 21. doi: 10.1093/brain/awx154 PMCID: PMC5841198 PMID: 29053779 Cell-based therapeutic strategies for multiple sclerosis Neil J Scolding,1 Marcelo…
Stuart Schlossman
video presentation Defining the “Pathways to Cures Roadmap” with global collaboration
The Printed version of this video can be read by clicking here…
Stuart Schlossman
